MENU

HALO Halozyme Therapeutics Forecast, Technical & Fundamental Analysis

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies... Show more

Industry: #Biotechnology
HALO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
HALO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

HALO is expected to report earnings to rise 13.12% to $1.81 per share on August 11

Halozyme Therapeutics HALO Stock Earnings Reports
Q2'26
Est.
$1.81
Q1'26
Beat
by $0.06
Q4'25
Missed
by $2.14
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.30
The last earnings report on May 11 showed earnings per share of $1.60, beating the estimate of $1.54. With 984.32K shares outstanding, the current market capitalization sits at 9.03B.
A.I. Advisor
published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
423
Web
https://www.halozyme.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XTIA1.450.04
+2.84%
XTI Aerospace Inc
CFR157.901.04
+0.66%
Cullen/Frost Bankers
AIV2.80N/A
N/A
Apartment Investment and Management Company
COTY2.24N/A
N/A
COTY
CAQUU10.02N/A
N/A
Cambridge Acquisition Corp

HALO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
-0.12%
AXON - HALO
47%
Loosely correlated
-3.32%
INCY - HALO
42%
Loosely correlated
-2.12%
VCYT - HALO
34%
Loosely correlated
+0.90%
GMAB - HALO
34%
Loosely correlated
-0.69%
RPRX - HALO
33%
Poorly correlated
+0.04%
More
Halozyme Therapeutics (HALO) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com